Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1389201022666210202142811 http://scihub22266oqcxt.onion/10.2174/1389201022666210202142811 33530904!ä!33530904 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Pharm+Biotechnol 2021 ; 22 (12): 1574-1583 Nephropedia Template TP {{tp|p=33530904|t=2021. BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check |pdf=|usr=}}{{33530904}} gab.com Text BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check JO: Curr Pharm Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=33530904 #FOAvip Since its origin in the Wuhan province of China in December 2019, Coronavirus Disease 19 (COVID-19) has spread to most parts of the world and has infected millions of people. However, the significant variability in the mortality rate across the world indicates some underlying factors, especially the immunity factors that may have a potential role in this variability. One such factor that is being discussed and tested is the Bacillus Calmette-Guerin (BCG) vaccine. The available evidence suggests that BCG vaccination provides broad protection against respiratory infections as well as other infections. Therefore, BCG may prove to be a barrier for COVID-19 infection and may offer a ray of hope. In this review, we contrasted BCG vaccination program with COVID-19 mortality and analyzed trained immunity and cross protection against unrelated pathogens due to BCG vaccination. On analyzing the available data, we observed that countries without universal BCG vaccination policy are severely affected, while countries having universal BCG policies are less affected. Based on these data, we propose that the SARS-CoV-2 related qualified immunity, cross protection against unrelated pathogens and COVID-19 impact variations could be partly explained by the different national policies regarding BCG childhood vaccination. The combination of reduced morbidity and mortality may make BCG vaccination a potential new tool in the fight against COVID-19. Twit Text FOAVip BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check ????Curr Pharm Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=33530904 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33530904 #FOAvip English Wikipedia <ref>{{Cite pmid|33530904}}</ref> BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check #MMPMID33530904 Pandita A; Bhat A; Koul A; Singh SK Curr Pharm Biotechnol 2021[]; 22 (12): 1574-1583 PMID33530904show ga Since its origin in the Wuhan province of China in December 2019, Coronavirus Disease 19 (COVID-19) has spread to most parts of the world and has infected millions of people. However, the significant variability in the mortality rate across the world indicates some underlying factors, especially the immunity factors that may have a potential role in this variability. One such factor that is being discussed and tested is the Bacillus Calmette-Guerin (BCG) vaccine. The available evidence suggests that BCG vaccination provides broad protection against respiratory infections as well as other infections. Therefore, BCG may prove to be a barrier for COVID-19 infection and may offer a ray of hope. In this review, we contrasted BCG vaccination program with COVID-19 mortality and analyzed trained immunity and cross protection against unrelated pathogens due to BCG vaccination. On analyzing the available data, we observed that countries without universal BCG vaccination policy are severely affected, while countries having universal BCG policies are less affected. Based on these data, we propose that the SARS-CoV-2 related qualified immunity, cross protection against unrelated pathogens and COVID-19 impact variations could be partly explained by the different national policies regarding BCG childhood vaccination. The combination of reduced morbidity and mortality may make BCG vaccination a potential new tool in the fight against COVID-19. |*BCG Vaccine[MESH] |*COVID-19[MESH] |China[MESH] |Humans[MESH] |SARS-CoV-2[MESH]BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality(epmc).pdf DeepDyve Pubget Overpricing